Levi & Korsinsky Reminds ADMA BIOLOGICS, INC. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 10, 2026 - ADMA
Pension funds and asset managers holding ADMA Biologics positions during the Class Period face potential fiduciary exposure as alleged channel stuffing scheme inflated ASCENIV revenues from $92.6 million to $362.5 million over two years. NEW YORK, July 29, 2026 /PRNewswire/ --...
Pension funds and asset managers holding ADMA Biologics positions during the Class Period face potential fiduciary exposure as alleged channel stuffing scheme inflated ASCENIV revenues from $92.6 million to $362.5 million over two years. NEW YORK, July 29, 2026 /PRNewswire/ --...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.